Vitamin K1 10mg/ml For Inj, 1ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the dosage instructions carefully. This medication is administered via injection into a muscle, vein, or under the skin (subcutaneously) in the fatty tissue.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- If you are taking warfarin, avoid large, sudden changes in your intake of vitamin K-rich foods (e.g., leafy green vegetables) as this can affect your INR. This is less critical when receiving injectable vitamin K for acute reversal.
- Report any signs of unusual bleeding or bruising to your doctor immediately.
- If you receive this injection, especially intravenously, report any discomfort, flushing, rash, or difficulty breathing immediately to your healthcare provider.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Flushing
Feeling tired or weak
Chest pain or pressure
Fast heartbeat or abnormal heartbeat
Dizziness or fainting
Shortness of breath
Excessive sweating
Blue or gray discoloration of the skin, lips, nail beds, fingers, or toes
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or do not go away, contact your doctor:
Pain, redness, or swelling at the injection site
* Change in taste
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe allergic reaction (difficulty breathing, swelling of face/throat, hives, rash, dizziness, rapid heartbeat)
- Signs of bleeding (unusual bruising, nosebleeds, blood in urine/stools, prolonged bleeding from cuts)
- Pain, swelling, or redness at the injection site
Before Using This Medicine
It is essential to inform your doctor about any allergies you have, including:
- An allergy to this medication or any of its components
- An allergy to other medications, foods, or substances
When discussing your allergies, be sure to describe the symptoms you experienced.
This medication may interact with other medications or health conditions. To ensure safe use, it is crucial to:
- Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins
- Share information about any health problems you have
You must verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.
Potential Skin Reactions
Skin reactions can occur with this medication, sometimes up to 1 year after administration. If you experience a rash or any other skin reaction, promptly consult with your doctor.
Aluminum Toxicity Risk
This medication may contain aluminum, which can increase the risk of aluminum toxicity with long-term use. This risk is higher if you have kidney problems or are a premature infant. Discuss this risk with your doctor to understand the potential implications.
Benzyl Alcohol Precaution
Some formulations of this medication contain benzyl alcohol. If possible, avoid using products with benzyl alcohol in newborns or infants, as serious side effects can occur with certain doses, especially when combined with other medications containing benzyl alcohol. Consult with your doctor to determine if this product contains benzyl alcohol.
Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. It is essential to discuss the benefits and risks of this medication to both you and your baby.
Reversing Blood Thinner Effects
This medication is used to reverse the effects of blood thinners, which are prescribed to prevent blood clots in individuals with certain health conditions. After using this medication, your risk of blood clots may increase. Follow your doctor's instructions carefully to minimize this risk and prevent blood clots.
Overdose Information
Overdose Symptoms:
- While rare with therapeutic doses, excessive doses could theoretically lead to overcorrection of coagulation, increasing risk of thrombosis, though this is less common than with other procoagulants.
- Hemolytic anemia, hyperbilirubinemia, and kernicterus have been reported in neonates, particularly with large doses of synthetic vitamin K analogs (menadione), but are rare with phytonadione.
What to Do:
Discontinue phytonadione. Monitor coagulation parameters (INR/PT). Supportive care. For severe overcorrection leading to thrombosis, anticoagulant therapy may be considered. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Major Interactions
- Warfarin (antagonistic effect, reverses anticoagulant action)
Moderate Interactions
- Mineral oil (may decrease absorption of oral vitamin K)
- Orlistat (may decrease absorption of oral vitamin K)
- Cholestyramine, Colestipol (may decrease absorption of oral vitamin K)
Monitoring
Baseline Monitoring
Rationale: To assess baseline coagulation status and determine the need for vitamin K.
Timing: Prior to administration.
Rationale: To assess hepatic function, as vitamin K is metabolized in the liver and clotting factors are synthesized there.
Timing: If hepatic impairment is suspected or known.
Routine Monitoring
Frequency: 6-24 hours after administration, then daily or as clinically indicated until target INR is achieved.
Target: Dependent on clinical indication (e.g., INR 2-3 for most anticoagulated patients, or normal range for deficiency).
Action Threshold: If INR remains elevated or bleeding persists, consider repeat dosing or alternative therapies.
Frequency: Continuously during IV infusion, then as per institutional protocol.
Target: Within normal limits.
Action Threshold: Hypotension, flushing, dyspnea, or chest pain may indicate an anaphylactoid reaction; stop infusion immediately.
Frequency: Continuously.
Target: Absence of active bleeding or new thrombotic events.
Action Threshold: New or worsening bleeding requires immediate assessment and intervention. New thrombotic events require investigation.
Symptom Monitoring
- Signs of bleeding (e.g., bruising, petechiae, epistaxis, hematuria, melena, hematemesis)
- Signs of allergic/anaphylactoid reaction (e.g., flushing, rash, urticaria, dyspnea, chest tightness, hypotension, dizziness, swelling of face/lips/tongue)
- Pain or swelling at injection site (for IM/SC)
Special Patient Groups
Pregnancy
Phytonadione is classified as Pregnancy Category C. While animal studies have shown adverse effects at high doses, human data are limited. It is generally considered safe and indicated for use in pregnant women when clinically necessary, particularly for the treatment of vitamin K deficiency or reversal of anticoagulation, as the benefits often outweigh the potential risks. It does not readily cross the placenta.
Trimester-Specific Risks:
Lactation
Phytonadione is excreted in breast milk in small amounts. However, the amount is generally considered too low to provide adequate prophylaxis against VKDB in breastfed infants. It is generally considered compatible with breastfeeding, and no adverse effects on breastfed infants have been reported. The benefits of breastfeeding typically outweigh the minimal risk.
Pediatric Use
Widely used in pediatric populations, especially neonates, for the prophylaxis and treatment of Vitamin K Deficiency Bleeding (VKDB). Dosing is weight-based and specific to age group and indication. IV administration should be slow and cautious due to risk of severe reactions.
Geriatric Use
No specific dose adjustments are typically required for geriatric patients. However, older adults may be more susceptible to adverse reactions, particularly with IV administration. Monitor closely for signs of bleeding, thrombosis, and hypersensitivity reactions. Co-morbidities and polypharmacy should be considered.
Clinical Information
Clinical Pearls
- Intravenous (IV) administration of phytonadione carries a risk of severe, sometimes fatal, anaphylactoid reactions (flushing, dyspnea, chest pain, hypotension). This route should be reserved for urgent situations where rapid reversal is critical and other routes are not feasible. If IV is used, it must be diluted and infused very slowly (over at least 30 minutes).
- Subcutaneous (SC) or intramuscular (IM) routes are generally preferred for non-emergent situations due to lower risk of anaphylactoid reactions, though absorption can be variable.
- Oral administration is effective for non-urgent warfarin reversal or chronic vitamin K deficiency, especially for INR values <10 without bleeding.
- Phytonadione is light-sensitive and should be protected from light during storage and administration.
- The onset of action for phytonadione is slower than prothrombin complex concentrates (PCCs) or fresh frozen plasma (FFP) for rapid reversal of severe bleeding, but its effect is more sustained.
- Response to phytonadione can be blunted in patients with severe liver disease due to impaired synthesis of clotting factors, even with adequate vitamin K.
Alternative Therapies
- Fresh Frozen Plasma (FFP): Provides immediate replacement of all clotting factors, used for rapid reversal of severe bleeding.
- Prothrombin Complex Concentrates (PCCs): Provide concentrated factors II, VII, IX, X (and sometimes protein C and S), used for very rapid reversal of severe bleeding, especially in warfarin-associated hemorrhage.
- Recombinant Factor VIIa (rFVIIa): Used off-label for severe bleeding, but has a higher thrombotic risk and is generally not first-line for warfarin reversal.